arrow
Back
G

Guillaume Cartron

Department of Hematology

68H-index
629Paper Count
1.9WCitation Count
Published Papers 145
Publication Date
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
err2026-08-21
err0
PREAI
errGuillaume Manson; Roberta Di Blasi; Roch Houot; Franck Morschhauser; Guillaume Cartron; Thomas Gastinne; Didier Blaise; François-Xavier Gros; Pierre Bories; Fabien Le Bras; Marie-Thérèse Rubio; Mohammad Mohty; Jacques-Olivier Bay; Stéphanie Guidez; Cristina Castilla Llorente; Fabrice Jardin; Amandine Durand; Blandine Guffroy; Michaël Loschi; Laurianne Drieu La Rochelle; Julie Abraham; Adrien Chauchet; Laura Herbreteau; Sylvain Choquet; Magalie Joris; Sylvain Carras; Gandhi-Laurent Damaj; Justine Decroocq; Tanguy-Schmidt Aline; Olivier Hermine; Emmanuelle Nicolas-Virelizier; Elodie Gat; Steven Le Gouill; Emmanuel Bachy; Remy Dulery
errShare
errSave
Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study
err2026-07-25
err0
PREAI
errYassine Al Tabaa; Clément Bailly; Xavier Palard-Novello; Anne-Ségolène Cottereau; Jérémie Tordo; Pierre Sesques; Guillaume Cartron; Roch Houot; Roberta Di Blasi; Guillaume Manson; Bastien Lesne; Loïc Ysebaert; Salim Kanoun; Emelie Van Zele; Steven Le Gouill; Benoît Tessoulin; Caroline Bodet-Milin; Françoise Kraeber-Bodéré; Laetitia Vercellino
errShare
errSave
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
err2026-07-16
err0
errOAAI
errMartin Hutchings; Michael Dickinson; Giuseppe Gritti; Carmelo Carlo-Stella; William Townsend; Francesc Bosch; Nancy L. Bartlett; Guillaume Cartron; Herve Ghesquieres; Roch Houot; Harriet Walter; Fritz Offner; Natalie Dimier; Candice Jamois; Sylvia Herter; Abiraj Keelara; Sabine Wilson; Jeremy Gallien; Heather Hinton; Isabel Prieto Gonzalez-Albo; Koorosh Korfi; Georgios Kazantzidis; Marie-Hélène Wasmer; Katharina Lechner; Franck Morschhauser
errShare
errSave
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL
errBlood
IF23.1
err2026-07-03
err0
errOAAI
errSairah Ahmed; Alejandro Martín García-Sancho; Juan Luis Reguera Ortega; Guillaume Cartron; Aaron P. Rapoport; Koji Izutsu; Hervé Ghesquieres; Hideki Goto; M. Lia Palomba; Jeremy S. Abramson; Peter Borchmann; Ulrich Jäger; Manali Kamdar; Martin Dreyling; Marion Subklewe; Saurabh Dahiya; Loretta J. Nastoupil; Merav Bar; Maria Strocchia; Martina Raggi
errShare
errSave
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm
err2026-07-01
err0
errOAAI
errGuillaume Cartron; Isabelle Chaillol; Roch Houot; Yassine Al Tabaa; Fabien Le Bras; Loïc Ysebaert; Sylvain Choquet; Fabrice Jardin; Jacques-Olivier Bay; François-Xavier Gros; Franck Morschhauser; Cédric Rossi; Thomas Gastinne; Catherine Thieblemont; Magalie Joris; Laure Ricard; Caroline Regny; Laurianne Drieu La Rochelle; Pierre Feugier; Ambroise Marcais; Romain Ould-Ammar; Karin Tarte; Camille Laurent; Pierre Sesques
errShare
errSave
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHL
errBlood
IF23.1
err2026-03-02
err0
PREAI
errPaul Marcoux; Fabien Gava; Marie Tosolini; Pauline Gravelle; Christina Schniederjohann; Sonia Quertinmont; Neus Serrat; Fanny Bouquet; Sylvia Herter; Karin Tarte; Mickael Roussel; Pierre Sesques; Caroline Bret; Cédric Rossi; Pierre Aubert; Franck Morschhauser; Guillaume Cartron; Wolfgang Huber; Sascha Dietrich; Loïc Ysebaert
errShare
errSave
Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphoma
err2026-01-13
err0
errOAAI
errEmilie Charton; Amélie Anota; Emmanuel Bachy; Guillaume Cartron; François-Xavier Gros; Franck Morschhauser; Lucie Oberic; Thomas Gastinne; Pierre Feugier; Remy Dulery; Catherine Thieblemont; Magalie Joris; Fabrice Jardin; Sylvain Choquet; Olivier Casasnovas; Gabriel Brisou; Morgane Cheminant; Jacques-Olivier Bay; Francisco Llamas Gutierrez; Cédric Portugues
errShare
errSave
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registry
err2025-10-24
err0
errOAAI
errFederico Erbella; Emmanuel Bachy; Guillaume Cartron; Elodie Gat; Guillaume Manson; Franck Morschhauser; Francois-Xavier Gros; Louise Roulin; Benoit Tessoulin; Pierre Bories; Olivier Tournilhac; Laure Ricard; Stéphanie Guidez; Sylvain Choquet; Rene-Olivier Casasnovas; Gabriel Brisou; Arnaud Campidelli; Cristina Castilla-Llorente; Fabrice Jardin; Emmanuel Gyan; Blandine Guffroy; Julie Abraham; Justine Decroocq; Adrien Chauchet; Magalie Joris; Fabien Claves; Sylvain Carras; Gaëlle Guillerm; Michaël Loschi; Olivier Hermine; Aline Taguy-Schimidt; Steven Le Gouill; Roch Houot; Roberta Di Blasi
errShare
errSave
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma
err2025-08-23
err0
errOAAI
errSara Ovejero; Julie Devin; Laura Alibert; Camille Soun; Yea-Lih Lin; Laure Dutrieux; Matthieu Abouladze; Elvira Garcia de Paco; Ouissem Karmous Gadacha; Angelos Constantinou; Guillaume Cartron; Charles Herbaux; Olivier Elemento; Philippe Pasero; Sandrine Roulland; Jérôme Moreaux; Caroline Bret
errShare
errSave
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics
err2025-08-14
err0
errOAAI
errDavid Ternant; Olivier Le Tilly; Guillaume Cartron; Céline Desvignes; Amina Bensalem; Denis Mulleman; Theodora Bejan-Angoulvant; Valérie Gouilleux-Gruart; Gilles Paintaud
errShare
errSave
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study
err2025-08-06
err0
errOAAI
errOlivier Tournilhac; Kamal Bouabdallah; Solene Lecolant; Maya Hacini; Kamel Laribi; Sébastien Bailly; Thibaut Belmondo; Marie Maerevoet; Loic Ysebaert; Stephanie Guidez; Steven Le Gouill; Christophe Bonnet; Marc André; Jehan Dupuis; Catherine Thieblemont; Emmanuel Bachy; Nicolas Daguindau; Franck Morschhauser; Sabine Tricot; Charline Moulin; Anne Banos; Roch Houot; Adrien Chauchet; Emmanuel Gyan; Guillaume Cartron; Hassan Farhat; Vincent Camus; Bernard Drenou; Hacene Zerazhi; David Sibon; Emmanuelle Nicolas-Virelizier; Caroline Delette; Sylvia Snauwaert; Sarah Bailly; Richard Delarue; Sylvain Carras; Albane Ledoux-Pilon; Marie Parrens; Samuel Griolet; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Gandhi Laurent Damaj
errShare
errSave
CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodies
err2025-07-20
err0
errOAAI
errDjamila Chemlal; Camille Pochard; Valentin Jacquier; Angélique Bruyer; Ludovic Gabellier; Léa Fornero; Clément Vempère; Amélie Machura; Guilhem Requirand; Nicolas Robert; Caroline Bret; Guillaume Cartron; Laure Vincent; Hugues de Boussac; Jérôme Moreaux; Charles Herbaux
errShare
errSave
The Arming of Natural Killer Cells With Fc-Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells
errMedComm
IF10.7
err2025-07-04
err0
errOAAI
errMichaël Constantinides; Loïs Coënon; Paolo Falvo; Caroline Multrier; Davide Lombardi; Francesco Bertolini; Pierre Martineau; Bruno Robert; Guillaume Cartron; Martin Villalba
errShare
errSave
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
err2025-04-03
err0
PREAI
errCartron, Guillaume; Houot, Roch; Al Tabaa, Yassine; Le Bras, Fabien; Ysebaert, Loic; Choquet, Sylvain; Jardin, Fabrice; Bay, Jacques-Olivier; Gros, Francois-Xavier; Morschhauser, Franck; Casasnovas, Olivier; Gastinne, Thomas; Thieblemont, Catherine; Joris, Magalie; Ricard, Laure; Regny, Caroline; La Rochelle, Laurianne Drieu; Feugier, Pierre; Marcais, Ambroise; Griolet, Samuel; Laurent, Camille; Sesques, Pierre
errShare
errSave
Personalized baseline and residual TMTV influence treatment response and outcomes in relapsed/refractory lymphomas: results from the GATA study
err2025-02-22
err0
PREAI
errMalmon, Solene; Casasnovas, Olivier; Fournier, Marguerite; Cartron, Guillaume; Kanoun, Salim; Cottereau, Anne Segolene; Herbaux, Charles; Al Tabaa, Yassine
errShare
errSave
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction
err2025-02-03
err0
errOAAI
errOvejero, Sara; Alibert, Laura; Devin, Julie; Caneque, Tatiana; Jacquier, Valentin; Romero, Andrea; Amar, Salome; Abouladze, Matthieu; Paco, Elvira Garcia de; Gadacha, Ouissem Karmous; Requirand, Guilhem; Robert, Nicolas; Zellagui, Miss Leriem; de Boussac, Hugues; Cartron, Guillaume; Chiche, Johanna; Ricci, Jean-Ehrland; Herbaux, Charles; Rodriguez, Raphael; Moreaux, Jerome; Bret, Caroline
errShare
errSave
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
err2025-01-20
err0
errOAAI
errMarouf, Amira; Chaubard, Sammara; Lievin, Raphael; Michot, Jean-Marie; Molinari, Nicolas; Rossignol, Julien; Cavalieri, Doriane; Golfier, Camille; Allangba, Olivier; Philippe, Laure; Tessoulin, Benoit; Chauchet, Adrien; Deau, Benedicte; Oberic, Lucie; Vargaftig, Jacques; Moignet, Aline; Clavert, Aline; Dulery, Remy; Brisou, Gabriel; Tardy, Stephanie; Fataccioli, Virginie; Houot, Roch; Casasnovas, Rene O.; Thieblemont, Catherine; Ghesquieres, Herve; Carras, Sylvain; Le Gouill, Steven; Cartron, Guillaume; Ribrag, Vincent; Cheminant, Morgane; Marcais, Ambroise; Suarez, Felipe; Marabelle, Aurelien; Tournilhac, Olivier; Damaj, Gandhi; Gaulard, Philippe; De Leval, Laurence; Lemonnier, Francois; Bachy, Emmanuel; Chevret, Sylvie; Hermine, Olivier; Couronne, Lucile; Jaccard, Arnaud
errShare
errSave
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma
err2024-11-28
err0
errOAAI
errFalchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel
errShare
errSave
Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errNastoupil, Loretta; Dahiya, Saurabh; Palomba, Maria Lia; Garcia-Sancho, Alejandro Martin; Reguera, Juan Luis; Kuruvilla, John; Jaeger, Ulrich; Cartron, Guillaume; Izutsu, Koji; Dreyling, Martin; Kahl, Brad S.; Ghesquieres, Herve; Ardeshna, Kirit; Goto, Hideki; Barbui, Anna Maria; Abramson, Jeremy S.; Borchmann, Peter; Fleury, Isabelle; Mielke, Stephan; Skarbnik, Alan P.; Kamdar, Manali; Karmali, Reem; Viardot, Andreas; Farazi, Thalia; Kao, Grace Shih Hui; Vedal, Min; Nishii, Rina; Papuga, Jessica; Kumar, Jinender; Morschhauser, Franck
errShare
errSave
5-y Follow-up of Combination of Ibrutinib, Obinutuzumab and Venetoclax for Patients with Newly Diagnosed Mantle Cell Lymphoma, the Oasis Trial
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errTessoulin, Benoit; Morschhauser, Franck; Chiron, David; Bouabdallah, Krimo; Cartron, Guillaume; Rossi, Cedric; Milin, Caroline; Fouillet, Ludovic; Herbaux, Charles; Tchernonog, Emmanuelle; Mcculloch, Rory; Gastinne, Thomas; Callanan, Mary B.; Le Gouill, Steven
errShare
errSave